Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Controlled Clinical Study to Compare Abciximab-bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-elevation Myocardial Infarction

NCT00712101 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT00712101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00712101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Controlled Clinical Study to Compare Abciximab-bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-elevation Myocardial Infarction
Lead sponsor
University of Leipzig
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
April 30, 2011
Enrollment
1,912 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

st-elevation myocardial infarction